PSA Screening Has Little Impact on Prostate Cancer-related Deaths, Study Shows

PSA Screening Has Little Impact on Prostate Cancer-related Deaths, Study Shows
PSA screening has a minimal impact on prostate cancer-specific mortality but increases the likelihood of other health complications deriving from overdiagnosis, a recent meta-analysis shows. The study, “Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis,” was published in the journal The BMJ. Measuring prostate-specific antigen (PSA) levels is a common approach for

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Edward Corlin says:

    PSA testing at age 70 saved my life. Contrary to popular opinion, not all prostate cancers are slow growing. My PSA numbers were doubling every six months, and I caught the cancer before it spread.

Leave a Comment

Your email address will not be published. Required fields are marked *